The exchange offer expires tomorrow, monitor for proration results and final tender numbers. Post-split-off, MDT will be a leaner entity without MiniMed's diabetes business, while MMED becomes a pure-play diabetes growth story.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Oct 8 $87.75entry
- T+1 · 6w ago +0.83%α +0.23% · $88.48
- T+5 · 5w ago +8.77%α +9.05% · $95.45
- T+20 · 12d ago +19.48%α +24.76% · $104.84
- T+27 · todayOpen
- T+60 · in 7w Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Medtronic announced the final exchange ratio of 4.5939 for its split-off of MiniMed Group, Inc. The exchange offer expires October 9, 2026, and Medtronic may exchange up to 225,361,295 MiniMed shares (plus an additional 27,452,053 if oversubscribed) for Medtronic ordinary shares. This filing confirms the deal mechanics are on track for imminent close.
Key Facts
- Final exchange ratio set at 4.5939 MiniMed shares per Medtronic ordinary share
- Exchange offer expires at midnight ET on October 9, 2026
- Medtronic offering up to 225,361,295 MiniMed shares, plus up to 27,452,053 additional shares if oversubscribed
- If oversubscribed, Medtronic would accept ~55,032,401 or ~49,056,639 Medtronic ordinary shares depending on whether it exchanges all remaining interest
- Goldman Sachs and BofA Securities are dealer managers
Financial Impact
No new financial figures disclosed; deal value not stated in filing
Risk Factors
- Oversubscription could lead to proration, reducing the number of MDT shares tendered
- Tax-free treatment is not guaranteed and depends on final IRS determination
- MiniMed's standalone performance post-separation is unproven
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 425 Filing (Primary) | 0001628280-26-065402 |
| Document: 0001628280-26-065402-index-headers.html | 0001628280-26-065402 |
| Document: 0001628280-26-065402-index.html | 0001628280-26-065402 |
| Document: 0001628280-26-065402.txt | 0001628280-26-065402 |
Track record
53 reports on MDT
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +15.30% at T+60 after the Jun 3, 2026 report. 9 of 11 went positive at some point.
Filters
- Nov 16, 2026today Press Release Neutral 4/10 Entry price pending
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $101.59 Now $102.88 +1.27% settles Feb 8
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $98.88 Now $102.88 +4.05% settles Feb 1
- Oct 19, 202628d ago 8-K Neutral 4/10 Entry $94.63 Now $102.88 +8.72% settles Jan 15
- Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
- Oct 16, 20264w ago Insider Cluster Bearish 5/10 Entry $92.77 Now $102.88 −10.90% settles Jan 14
- Oct 15, 20264w ago 144 Neutral 3/10 Entry $95.45 Now $102.88 +7.78% settles Jan 12
- Oct 14, 20264w ago SC TO-I/A Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
- Oct 14, 20264w ago 425 Neutral 5/10 Entry $94.23 Now $102.88 +9.18% settles Jan 11
- Oct 13, 20264w ago SC TO-I/A Neutral 5/10 Entry $93.01 Now $102.88 +10.61% settles Jan 8
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers